| NCT ID | NCT07554118 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oklahoma |
| Condition | Older |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-01-30 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators propose a 2-week intervention involving adults over 65 years old. Participants will undergo dynamic balance training on an movable platform (stabilometer) with either restricted or full vision. The primary objective is to facilitate sensory re-weighting, hypothesizing that restricted vision training will increase somatosensory input utilization for postural control. Pre- and post-training assessments will measure postural control during gait initiation under a dual-task condition. The investigators hypothesize that the restricted vision group will demonstrate: 1. Improved postural control, indicated by increased center of pressure displacement during gait initiation. 2. Improved ability to utilize somatosensory input during a balance task.
Eligibility Criteria
Inclusion Criteria: 1. age 65 and above 2. able to walk continuously for at least 10 min without assistive device 3. have normal or corrected-to-normal vision. Exclusion Criteria: 1. neurological conditions such as stroke, Parkinson's disease, multiple sclerosis, brain tumor that significantly affect balance task and walking 2. known peripheral neuropathy that influence sensation 3. known vestibular dysfunction 4. known cognitive impairments 5. self-reported pain or musculoskeletal conditions that will significantly affect balance task and walking. 6. Drug use in the past 3 month. 7. At-risk drinker -
Contact & Investigator
Yo Shih, PhD
PRINCIPAL INVESTIGATOR
University of Oklahoma
Frequently Asked Questions
Who can join the NCT07554118 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 80 Years, studying Older. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07554118 currently recruiting?
Yes, NCT07554118 is actively recruiting participants. Contact the research team at Yo-shih@ou.edu for enrollment information.
Where is the NCT07554118 trial being conducted?
This trial is being conducted at Oklahoma City, United States.
Who is sponsoring the NCT07554118 clinical trial?
NCT07554118 is sponsored by University of Oklahoma. The principal investigator is Yo Shih, PhD at University of Oklahoma. The trial plans to enroll 30 participants.